Chicago, IL, United States of America

Gokay Yamankurt

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Northwestern University. Active years: 2026.

USPTO Granted Patents = 1 

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Gokay Yamankurt: Innovator in Nucleic Acid Research

Introduction

Gokay Yamankurt is a notable inventor based in Chicago, IL (US). He has made significant contributions to the field of nucleic acid research. His innovative work has led to the development of a unique patent that showcases his expertise and creativity.

Latest Patents

Gokay Yamankurt holds a patent for a "Hairpin-Like Oligonucleotide-Conjugated Spherical Nucleic Acid." This invention represents a significant advancement in the application of nucleic acids in various scientific fields. The patent highlights his ability to merge complex scientific concepts into practical applications.

Career Highlights

Yamankurt is affiliated with Northwestern University, where he continues to engage in groundbreaking research. His work at the university has allowed him to explore new frontiers in the field of molecular biology. With a total of 1 patent, he has established himself as a key figure in his area of expertise.

Collaborations

Throughout his career, Gokay Yamankurt has collaborated with esteemed colleagues, including Chad A. Mirkin and Matthew K. Vasher. These collaborations have further enriched his research and contributed to the advancement of scientific knowledge in nucleic acid applications.

Conclusion

Gokay Yamankurt is a distinguished inventor whose work in nucleic acid research has made a lasting impact. His innovative patent and collaborations with leading scientists underscore his commitment to advancing scientific understanding. His contributions continue to inspire future research in the field.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…